Dual Orexin Receptor Antagonist Attenuates Increases in IOP, ICP, and Translaminar Pressure Difference After Stimulation of the Hypothalamus in Rats

PURPOSE: Intraocular pressure (IOP) remains the only modifiable risk factor for glaucoma progression. Our previous discovery that stimulation of nuclei within the hypothalamus can modulate IOP, intracranial pressure (ICP), and translaminar pressure difference (TLPD) fluctuations led us to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: DeCarlo, Arthur A., Hammes, Nathan, Johnson, Philip L., Shekhar, Anantha, Samuels, Brian C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Glaucoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899853/
https://www.ncbi.nlm.nih.gov/pubmed/35234838
http://dx.doi.org/10.1167/iovs.63.3.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899853/
https://www.ncbi.nlm.nih.gov/pubmed/35234838
http://dx.doi.org/10.1167/iovs.63.3.1

Ejemplares similares